Shenzhen Jymed Technology Co Ltd, based in China, is a pharmaceutical company.
One of their notable products is DEGARELIX ACETATE, with a corresponding US DMF Number 33550.
Remarkably, this DMF maintains an Active status since its submission on February 21, 2019, highlighting commitment to regulatory compliance.
Their GDUFA DMF Review was successfully complete, with a review date of April 09, 2019, and payment made on March 01, 2019, indicating their dedication to facilitating drug approvals, Categorized as Type II